PATIENT ALERT: Virginia Oncology Associates now requires all patients and visitors to complete our online pre-COVID screening 72 hours prior to your appointment. Please CLICK HERE to complete the questionnaire.  Masks are still required in all offices.   Information regarding COVID-19.  

Another Advance in Immunotherapy: CAR T-cell Therapy

June 26, 2019

By: Daniel Aruch, MD, oncologist at Virginia Oncology Associates

It’s an exciting time for oncologists as numerous advances in immunotherapy allow us to offer more treatment options and greater hope to our patients. In the treatment of advanced blood cancers, chimeric antigen receptor (CAR) T-cell therapy is offering meaningful, long-lasting results. CAR T-cell therapy is currently approved in acute lymphoblastic leukemia (ALL) and diffuse large B-cell lymphoma (DLBCL).

Read More Categories: Cancer Treatment, Immunotherapy, Car T-Cell Therapy

1